Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer (Q84420058)
Jump to navigation
Jump to search
scientific article published on 17 August 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer |
scientific article published on 17 August 2009 |
Statements
Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer (English)
Petr Zatloukal
Jaromir Roubec
Karijn Floor
Jaromir Musil
Milan Kuta
Rob J van Klaveren
Subhash Chaudhary
Adrie Gunther
Setareh Shamsili